Related Experiment Video
Updated: Jun 1, 2026

Characterization of Recombination Effects in a Liquid Ionization Chamber Used for the Dosimetry of a Radiosurgical Accelerator
Published on: May 9, 2014
Water equivalent path length measurement in proton radiotherapy using time resolved diode dosimetry
B Gottschalk1, S Tang, E H Bentefour
1Laboratory for Particle Physics and Cosmology, Harvard University, 18 Hammond Street, Cambridge, Massachusetts 02138, USA. bgottsch@fas.harvard.edu
This study demonstrates a new method using diode dosimetry to accurately measure water equivalent path length (WEPL) in proton radiotherapy before treatment. This technique offers submillimeter precision for verifying proton beam energy, enhancing treatment accuracy.
Area of Science:
- Medical Physics
- Radiation Oncology
- Dosimetry
Background:
- Proton radiotherapy requires precise verification of the water equivalent path length (WEPL) to ensure accurate dose delivery.
- In vivo dosimetry methods are crucial for real-time verification of treatment parameters before patient exposure.
Purpose of the Study:
- To validate the use of time-resolved in vivo diode dosimetry for pre-treatment verification of WEPL in proton radiotherapy.
- To assess the accuracy and feasibility of this method for adjusting proton beam energy.
Main Methods:
- A passively scattered, range-modulated proton beam was used with a diode and fast current-to-voltage amplifier.
- Diode output was recorded at various depths in a water tank, observing bursts of proton pulses.
- The root-mean-square duration of these bursts was computed and fitted with a cubic polynomial for calibration.
Main Results:
- The method accurately determined unknown depths within 0.3 mm root-mean-square.
- A calibration curve derived from the polynomial allowed for precise depth determination.
Conclusions:
- Diode dosimetry, potentially integrated with devices like rectal balloons, can determine in vivo WEPL with submillimeter accuracy prior to proton therapy.
- This allows for beam energy adjustments, with minimal associated dose (approx. 0.2% of a single fraction dose).
More Related Videos
09:49A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
Published on: April 24, 2020
06:20Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021